Drugs / Geranium (Pelargonium graveolens) essential oil (EO)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06527066 | Sep 2024 → Jun 2025 overdue | — | University of Sao Paulo | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Geranium (Pelargonium graveolens) essential oil (EO) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06527066 ↗ |
| Known as | geranium EO | “In G2 there will be participants who will receive intervention with geranium EO (Pelargonium graveolens), diluted in All.me Beauty® Gel Sérum Biocompatível, respecting a...” NCT06527066 ↗ |
| Route | Topical | “through a protocol of topical facial application” NCT06527066 ↗ |